testosterone cypionate fda package insert

Testosterone Cypionate: Package Insert and Label Information

Corona, CA 92880 USA (click image for full-size original) testosterone cypionate testosterone cypionate injection, solution Product Information Product Type human prescription drug Item Code (Source) NDC: Route of Administration intramuscular

DEA Schedule ciii Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength testosterone cypionate (testosterone). Use over long periods may result in fusion of the epiphyseal growth centers and termination of the growth process. Other side effects that have occurred with some androgens include hirsutism, male pattern baldness, seborrhea, acne, retention of sodium, chloride, water, potassium, calcium and inorganic phosphates, nausea, cholestatic jaundice, alterations in liver function tests, suppression of clotting factors II, V, VII and X, bleeding. Adverse reactions: The following adverse reactions in the male have occurred with some androgens: Endocrine and Urogenital: Gynecomastia and excessive frequency and duration of penile erections. Testosterone Cypionate: Package Insert and Label. The steroid-receptor complex is transported to the nucleus where it initiates transcription events and cellular changes related to androgen action. Testosterone use may increase the risk. Description: Testosterone Cypionate Injection for intramuscular injection, contains testosterone cypionate which is the oil-soluble 17 (beta)- cyclopentylpropionate ester of the androgenic hormone testosterone. Testosterone Cypionate; FDA MedWatch. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Information for Patients: Patients should be instructed to report any of the following: nausea, vomiting, changes in skin color, ankle swelling, too frequent or persistent erections of the penis. Edema, with or without congestive heart failure, may be a serious complication in patients with pre-existing cardiac, renal or hepatic disease. There have been postmarketing reports of venous thromboembolism (VTE) in men taking testosterone, including testosterone cypionate. Testosterone Cypionate Injection is indicated for. Hematologic: Suppression of clotting factors II, V, VII, and X, results bleeding in patients on concomitant anticoagulant therapy, and polycythemia.

cypionate, insert, testosterone, package, fda | Category: Injection Steroids, Akrihin

injectable steroids buy online

Last revised: testosterone cypionate- testosterone cypionate injection, solution. Drugs in this class also cause retention of nitrogen, sodium, potassium, and phosphorus, and decreased urinary excretion of calcium. Drug Abuse And steroids injections side effects on human body Dependence Controlled Substance Class Testosterone is a controlled substance under the Anabolic Steroids Control Act, and depo-Testosterone Injection has been assigned to Schedule III. Gastrointestinal: Nausea, cholestatic jaundice, alterations in liver function tests, rarely hepatocellular neoplasms and peliosis hepatis (see, warnings ). We wont share. Benzyl alcohol has been reported to be associated with a fatal "Gasping Syndrome" in premature infants. Testosterone is also known to increase the number of tumors and decrease the degree of differentiation of chemically-induced carcinomas of the liver in rats. During exogenous administration of androgens, endogenous testosterone release is inhibited through feedback inhibition of pituitary luteinizing hormone (LH). Androgens are responsible for the growth spurt of adolescence and for eventual termination of linear growth, brought about by fusion of the epiphyseal growth centers.